News

The product is presently in the development stage for the treatment of chemotherapy-induced nausea and vomiting (CINV). As per the terms of the deal, Vifor Pharma will not

The power of cognitive computing capabilities, such as IBM’s Watson, will be exploited under the project. The project will leverage big data and analytics to deliver personalised care

The new lab allows the company to better support the business needs of its clients by increasing efficiency during discovery and development, and providing consistency in the stages

The contract is funded by the Defense Threat Reduction Agency (DTRA). According to the terms of the company’s contract with the Science and Technology Corporation, anti-ricin antibodies will

The transaction includes Iberogast and Laif brands indicated for the treatment of functional gastrointestinal disorders and for the treatment of mild to moderate depression respectively. The privately held

OneSource strategic lab solutions will deliver PerkinElmer’s informatics, instrumentation, service and process optimization, to increase laboratories’ productivity and performance. Due to limited access to laboratory personnel, the information

ORMD-0801 is an orally ingestible insulin capsule indicated for the early stages of type 2 diabetes, when it can still slow the rate of degeneration of the disease

The company has received the final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fenofibrate, which is the generic

Nemonoxacin is the first pharmaceutical product to be included in Cross-Strait Cooperation Agreement on Medicine and Public Health Affairs of the Economic Cooperation Framework Agreement (ECFA) between Taiwan